Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of €39.87 and traded as high as €40.70. Fresenius Medical Care shares last traded at €40.14, with a volume of 1,082,687 shares traded.
Fresenius Medical Care Stock Performance
The firm has a market cap of $11.93 billion, a PE ratio of 18.11, a PEG ratio of 0.42 and a beta of 0.94. The firm’s 50 day moving average price is €41.80 and its two-hundred day moving average price is €39.88. The company has a debt-to-equity ratio of 87.31, a quick ratio of 0.80 and a current ratio of 1.07.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
